Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study.

MLA

Barone, Paolo, et al. “Pramipexole versus Sertraline in the Treatment of Depression in Parkinson’s Disease: A National Multicenter Parallel-Group Randomized Study.” Journal of Neurology, vol. 253, no. 5, May 2006, pp. 601–07. EBSCOhost, https://doi.org/10.1007/s00415-006-0067-5.

APA

Barone, P., Scarzella, L., Marconi, R., Antonini, A., Morgante, L., Bracco, F., Zappia, M., & Musch, B. (2006). Pramipexole versus sertraline in the treatment of depression in Parkinson’s disease: a national multicenter parallel-group randomized study. Journal of Neurology, 253(5), 601–607. https://doi.org/10.1007/s00415-006-0067-5

Chicago

Barone, Paolo, Leonardo Scarzella, Roberto Marconi, Angelo Antonini, Letterio Morgante, Fulvio Bracco, Mario Zappia, and Bruno Musch. 2006. “Pramipexole versus Sertraline in the Treatment of Depression in Parkinson’s Disease: A National Multicenter Parallel-Group Randomized Study.” Journal of Neurology 253 (5): 601–7. doi:10.1007/s00415-006-0067-5.